BMJ  2003;327:395-396 (16 August), doi:10.1136/bmj.327.7411.395-b

Letter

Older patients are eligible for trial of lithium and valproate

The first 150 words of the full text of this article appear below.

EDITOR—Shulman et al report an increase in the prescription of valproate for elderly patients with bipolar disorder in Canada (and corresponding decrease in prescription of lithium).1 A similar pattern has been observed in the United States over the past decade or so.2 As the authors note, this change has occurred despite the limited evidence supporting the use of valproate and may indeed reflect concerns about lithium toxicity in elderly patients.

The BALANCE trial (www.psychiatry.ox.ac.uk/balance/), which is currently recruiting in the United Kingdom and soon to begin recruiting in the United States, should provide reliable evidence about the use of both lithium and valproate in bipolar disorder.3 A recent trial comparing lithium, valproate, and placebo did not find a significant difference between the treatments, probably because the inclusion of an untreated control arm meant that it was difficult to recruit patients who were judged at substantial risk . . . [Full text of this article]

Jennifer M Rendell, BALANCE trial manager

jennifer.rendell@psych.ox.ac.uk

John R Geddes, professor of epidemiological psychiatry

Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX

Michael J Ostacher, instructor in psychiatry

Harvard Bipolar Research Program, Massachussetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA 02114, USA on behalf of the BALANCE Investigators


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence
Kenneth I Shulman, Paula Rochon, Kathy Sykora, Geoffrey Anderson, Muhammad Mamdani, Susan Bronskill, and Chau T T Tran
BMJ 2003 326: 960-961. [Extract] [Full Text] [PDF]

New trial should clarify lithium use in bipolar disorder
John Geddes, Guy Goodwin, Jennifer Rendell, Jane Hainsworth, Emma Van der Gucht, and Heather Young
BMJ 2002 325: 441. [Extract] [Full Text]

Rapid Responses:

Read all Rapid Responses

Fears of lithium toxicity
Irene Mazis, et al.
bmj.com, 27 Aug 2003 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ